The Company today announced the launch of INSAIDA, a new video news program designed to deliver deeper visual analysis of business, economics and society INSAIDA combines Business Insider Japan's editorial reporting with video-native storytelling to meet the growing demand for trustworthy, easy-to-understand news in video format The program leverages Business Insider Japan's multi-angle coverage and […]

Impilo, a leading provider in enabling at-home healthcare through software, logistics, and operations support, announced a strategic partnership between its e-commerce store, The Digital Health Store, a trusted online destination empowering clinicians and everyday individuals to take charge of their health, and Eko Health, a leader in AI-powered cardiac and pulmonary disease detection. https://mma.prnewswire.com/media/2831201/Eko_Impilo_press_release_Logo.jpg Through

Old Republic International Corporation (NYSE: ORI) -today announced its Board of Directors has declared a regular quarterly cash dividend of 29 cents per share. This dividend is payable on December 15, 2025 to shareholders of record on December 5, 2025. That brings the full year's cash dividend to $1.16 per share compared to $1.06 per

Delivers 5.7% Comp Sales Growth for the DICK'S Business(A) – Raises FY 2025 Guidance(B) for Comp Sales Growth and EPS for the DICK'S Business(C) – Completed Acquisition of Foot Locker to Become a Global Leader in the Sports Retail Industry – — Delivered earnings per diluted share of $0.86 and non-GAAP earnings per diluted share

(NASDAQ:MOB),(NASDAQ:MOBBW),(AUST:MOB.AX), Mobilicom believes that follow-on orders are expected, driving Mobilicom's expansion in the strategic and growing European market for unmanned systems Palo Alto, California, Nov. 25, 2025 (GLOBE NEWSWIRE) — Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or the “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced it has secured

LONDON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Airtory, a dynamic creative management platform specializing in immersive and high-performing rich media advertising, today announced a strategic partnership with CultureSync Media, a marketing agency specializing in culturally relevant storytelling and data-driven advertising solutions to drive growth and engagement across Asia. This collaboration brings together Airtory's breakthrough technology

(NasdaqGM:HERE), BEIJING, Nov. 25, 2025 (GLOBE NEWSWIRE) — Here Group Limited (NASDAQ: HERE) (“Here” or the “Company”), a pop toy company dedicated to creating beloved collectibles and trend-defining experiences, today announced that it plans to release its unaudited financial results for the quarter ended September 30, 2025, before the U.S. market opens on Tuesday, December

(CNSX:SPAI.CN),(OTC US:SPAIF),(Other OTC:SPAIF),(Boerse Frankfurt – Freiverkehr:5OV0), VANCOUVER, British Columbia, Nov. 25, 2025 (GLOBE NEWSWIRE) — SPARC AI Inc. (the “Company”) (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) SPARC AI has taken delivery of two custom-built STRIKE-1 drones. These aircraft will be used as dedicated platforms for demonstrating the company's target acquisition system and autonomous navigation technology.

(CNSX:MAXX),(CNSX:MAXX.CN),(Pinksheets:MAXXF),(PinkSheets:MAXXF),(Boerse Frankfurt – Freiverkehr:89N.F),(Boerse Frankfurt – Freiverkehr:89N), New Video: MAX Power Leaps at Lawsonhttps://www.youtube.com/watch?v=Yr4Ha06__Eg MAX Power Saskatchewan Natural Hydrogen Documentary Videohttps://www.maxpowermining.com/NaturalHydrogen-NewEra/ SASKATOON, Saskatchewan, Nov. 25, 2025 (GLOBE NEWSWIRE) — MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) (“MAX Power” or the “Company”) is pleased to announce that the Company has completed Canada's first-ever

(NasdaqGM:RAPP), BOSTON and SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that the Company will present the results of its Phase 2a